Clinical Trial Update: Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of docetaxel (Taxotere) and vinorelbine (Navelbine) with G-CSF in stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Navelbine (vinorelbine)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Washington | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED